Aeolus Pharmaceuticals Inc. announced unaudited consolidated financial results for the first quarter ended December 31, 2014. For the quarter, the company reported a net loss of approximately $698,000 or $0.01 per share compared to $695,000 or $0.01 per share, for the three months ended December 31, 2013. Revenue was approximately $925,000 versus revenue of $793,000 for the three months ended December 31, 2013.

Loss from operations was $698,000 against $695,000 a year ago. Net cash used in operating activities was $1,070,000 against $335,000 a year ago.